White & Case advises Exponent Private Equity on financing of investment in Xeinadin Group
1 min read
Global law firm White & Case LLP has advised Exponent Private Equity (Exponent) on the debt finance aspects of a significant investment in the Xeinadin Group "(Xeinadin), a group of business advisory and accountancy practices formed through a transformative merger in 2019.
"Our team helped to navigate the financing aspects of this strategic investment successfully for our client, which will support Xeinadin's strategy for growth, allowing it to make further investments in innovative data-driven technologies to enhance service delivery to its clients," said White & Case partner Colin Harley, who led the Firm's team.
Exponent is one of the UK's leading private equity firms that seeks to identify untapped potential in order to unlock meaningful growth for its portfolio companies and investors. It invests in companies headquartered across Europe. Funds advised by Exponent have funds under management of around £2.9 billion. Created via the combination of more than 100 small and medium-sized businesses, Xeinadin is a large consolidator in the professional services market, with around 100 locations across the UK and Ireland.
The White & Case team in London which advised on the transaction was led by partner Colin Harley and included associates Nicolle Odutoye, Eline Souffriau and Ally Hammond.
For more information please speak to your local media contact.